Pulmonary hypertension treatment can help slow disease progression, ease symptoms, and improve quality of life for people with the disease.

PAH has increased worldwide in older adults, largely due to growing aging populations, with the greatest risk factors in ...

Time is a precious commodity, says columnist Jolie Lizana, who spends too many hours each month managing her health with PH.

Anticoagulant therapy does not extend survival in people with PAH, according to a French study involving the blood thinners.

Researchers developed PVC, a measure that estimates the reduced function of the pulmonary arteries in pediatric PAH patients, per a study.

The term "October slide" refers to a trend in which many in the chronic illness community face health setbacks, writes ...

Long-term treatment with Tyvaso DPI is safe and effective in adults with PAH who were previously on Tyvaso, according to ...

The strategy begins with medications, followed by balloon pulmonary angioplasty, and pulmonary endarterectomy surgery, a ...

A new experimental therapy for pulmonary arterial hypertension (PAH), called ALG-801, has shown superior efficacy over current standard-of-care treatments in early laboratory studies, according to its ...

Worldwide, pulmonary arterial hypertension (PAH) affects more than 2 of every 100,000 females ages 15 to 49 — women and girls of childbearing age — according to a new analysis of data spanning some ...